Find therapies in clinical trials near you – page 204

Study on the Effects of Ianalumab in Patients with Sjögren's Syndrome

Study on the Effects of Ianalumab in Patients with Sjögren's Syndrome

Study of M9140 for Patients with Advanced Non-Small Cell Lung Cancer

Study of M9140 for Patients with Advanced Non-Small Cell Lung Cancer

Study of Bleximenib with Drug Combination for Patients with Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

Study of Bleximenib with Drug Combination for Patients with Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

Study of M9140 for Patients with Advanced Stomach Cancer

Study of M9140 for Patients with Advanced Stomach Cancer

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Study on the Effects of Maplirpacept, Glofitamab, and Obinutuzumab in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma Not Eligible for Stem Cell Transplant

Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome

Study on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome

Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Study on the Safety and Effects of NVG-2089 for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Study on Sotatercept for Treating Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction

Study on Sotatercept for Treating Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction

Study of Teclistamab for Patients with Previously Treated AL Amyloidosis

Study of Teclistamab for Patients with Previously Treated AL Amyloidosis

Study of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation

Study of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation